Cite
HARVARD Citation
Massaro, F. et al. (2022). Brentuximab vedotin consolidation after autologous stem cell transplantation for Hodgkin lymphoma: A Fondazione Italiana Linfomi real‐life experience. Hematological oncology. 40 (1), pp. 32-40. [Online].